Puri Pankaj
Department of Gastroenterology, Army Hospital (Research and Referral), Dhaula Kuan, New Delhi 110010, India.
J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S27-33. doi: 10.1016/j.jceh.2013.05.015. Epub 2014 Jan 2.
The pathogenesis of portal cavernoma cholangiopathy (PCC) is important as it can impact the choice of treatment modalities. PCC consists of a reversible component, which resolves by decompression of collaterals as well as a fixed component, which persists despite the decompression of collaterals. The reversible component is due to compression by large collaterals located adjacent to the bile duct as well as possibly intracholedochal varices. The fixed component is likely to be due to ischemia at the time of portal vein thrombosis, local ischemia by compression as well as encasement by a solid tumor-like cavernoma comprising of fibrous hilar mass containing multiple tiny collateral veins rather than markedly enlarged portal collaterals. Although cholangiographic abnormalities in portal hypertension are common, the prevalence of symptomatic PCC is low. This is likely to be related to the cause of portal hypertension, the duration of portal hypertension and possibly the pattern of occlusion of the splenoportal axis. There may possibly be higher prevalence of symptomatic PCC in extension of the thrombosis to the splenomesentric veins.
门静脉海绵样变性胆管病(PCC)的发病机制很重要,因为它会影响治疗方式的选择。PCC由一个可逆成分和一个固定成分组成,可逆成分通过侧支循环减压而缓解,而固定成分即使在侧支循环减压后仍持续存在。可逆成分是由于位于胆管附近的大侧支循环以及可能的胆管内静脉曲张压迫所致。固定成分可能是由于门静脉血栓形成时的缺血、压迫导致的局部缺血以及由包含多个微小侧支静脉而非明显扩张的门静脉侧支的纤维性肝门肿块样海绵状瘤包绕所致。尽管门静脉高压中的胆管造影异常很常见,但有症状的PCC患病率较低。这可能与门静脉高压的病因、门静脉高压的持续时间以及脾门静脉轴的闭塞模式有关。在血栓延伸至脾肠系膜静脉时,有症状的PCC患病率可能更高。